Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: <i>in vitro</i> , <i>in silico</i> studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors

Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, Abdul Hameed, Jamshed Iqbal

RSC Advances · 2024 · 20 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

component, unveiling critical interactions, specifically the hydrogen bonding interaction, π-π, π-alkyl, π-amid and π-sulfur interactions between the ligand and enzymes. These findings suggest that compounds a5, a6, a11, a12, a15, and a18 may be potent multifunctional candidates for AD treatment.

References

23